News | Radiology Business | December 14, 2023

Kathy Spencer-Pike brings more than two decades of experience within highly matrixed Fortune 50 environments as well as fast-paced growth and start-up enterprises

Nucleus RadioPharma, a fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer

Katherine Spencer-Pike, Photo: Business Wire


December 14, 2023 — Nucleus RadioPharma, a fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer. As a seasoned veteran with decades of commercial experience at McKesson, Novo Nordisk, Sanofi and Pfizer, Spencer-Pike will be responsible for accelerating the growth of the startup following its oversubscribed $56M Series A in October. Spencer-Pike follows a string of C-Suite appointments including Geoff Johnson, M.D., Ph.D. as Chief Scientific Officer, Kevin Haehl as Chief Development Officer and Mark Przekop as Chief Operating Officer.

“Kathy’s sterling track record of enhancing organizational value, paired with her expertise in creating, developing, and leading high-achieving teams in new business, client success, and business expansion is the perfect addition to round out our C-Suite,” said Charles S. Conroy, CEO of Nucleus RadioPharma. “On the heels of our successful funding round to increase the radiopharmaceutical accessibility, we are eager to lean on Kathy’s experience and insight to accelerate further growth and advance our commitment to delivering life-saving treatments to patients with cancer.”

Before Nucleus, Spencer-Pike was Chief Sales Officer at McKesson where she spurred significant company growth, built a high-performance commercial team and merged three legacy organizations into a single commercial organization achieving unprecedented double-digit growth year over year. Spencer-Pike previously was VP, Commercial Leader for Novo Nordisk, successfully leading the planning, development and execution of market and sales strategies, exceeding revenue goals. In addition to her commercial experience, Spencer-Pike is a dedicated advocate for DE&I, leading the largest US-based Women’s Employee Resource Group (ERG) at Pfizer and Novo Nordisk, both of which were the largest ERGs within the companies. This experience speaks to her commitment to growth and development and fostering inclusive cultures.

For more information: https://nucleusrad.com/


Related Content

News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | SNMMI

June 13, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted more than 8,000 physicians ...

Time June 13, 2024
arrow
News | PET-CT

June 13, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 13, 2024
arrow
News | Radiology Business

June 12, 2024 — Cathy Sue Cutler, PhD, FSNMMI, chair of the Isotope Research and Production Department at Brookhaven ...

Time June 12, 2024
arrow
News | Neuro Imaging

June 12, 2024 — Brainet, a developer of cutting-edge diagnostic tools for assessing brain health, and SimonMed Imaging ...

Time June 12, 2024
arrow
News | SNMMI

June 11, 2024 — Heather Jacene, MD, assistant chief of Nuclear Medicine and Molecular Imaging at Brigham and Women’s ...

Time June 11, 2024
arrow
News | SNMMI

June 11, 2024 — The Society of Nuclear Medicine and Molecular Imaging recognized six new SNMMI Fellows during a plenary ...

Time June 11, 2024
arrow
News | SPECT-CT

June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac ...

Time June 11, 2024
arrow
News | PET Imaging

June 11, 2024 — A new ultra-high-performance brain PET system allows for the direct measurement of brain nuclei as never ...

Time June 11, 2024
arrow
Subscribe Now